Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes.

Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes.
复制标题

DOI:
10.1021/ml4000673
复制
发表时间:
2013-05-09
影响因子:
4.2
通讯作者:
Ulven, Trond
Ulven, Trond
中科院分区:
医学3区
文献类型:
--
作者:
Christiansen, Elisabeth;Hansen, Steffen V. F.;Urban, Christian;Hudson, Brian D.;Wargent, Edward T.;Grundmann, Manuel;Jenkins, Laura;Zaibi, Mohamed;Stocker, Claire J.;Ullrich, Susanne;Kostenis, Evi;Kassack, Matthias U.;Milligan, Graeme;Cawthorne, Michael A.;Ulven, Trond

文献摘要

参考文献

被引文献

相似文献

游离脂肪酸受体1 (FFA1或GPR40)可增强胰腺β细胞葡萄糖刺激的胰岛素分泌,目前作为治疗2型糖尿病的新靶点备受关注。我们在此报告发现了一种高效的FFA1激动剂,具有良好的物理化学和药代动力学性质。这种化合物有效地使饮食诱导的肥胖小鼠的葡萄糖耐量正常化,这种效果在29天的慢性剂量后完全持续。
Free fatty acid receptor 1 (FFA1 or GPR40) enhances glucose-stimulated insulin secretion from pancreatic β-cells and currently attracts high interest as a new target for the treatment of type 2 diabetes. We here report the discovery of a highly potent FFA1 agonist with favorable physicochemical and pharmacokinetic properties. The compound efficiently normalizes glucose tolerance in diet-induced obese mice, an effect that is fully sustained after 29 days of chronic dosing.
DOI: 10.1038/nrd2445
发表时间: 2007-11-01
影响因子: 120.1
作者:
Leeson, Paul D.;Springthorpe, Brian
通讯作者: Springthorpe, Brian
DOI: 10.1021/ml100106c
发表时间: 2010-10-01
影响因子: 4.2
作者:
Christiansen, Elisabeth;Due-Hansen, Maria E.;Ulven, Trond
通讯作者: Ulven, Trond
DOI: 10.1021/ml1000855
发表时间: 2010-09-01
影响因子: 4.2
作者:
Negoro, Nobuyuki;Sasaki, Shinobu;Momose, Yu
通讯作者: Momose, Yu
DOI: 10.1021/jo902533p
发表时间: 2010-02-19
影响因子: 3.6
作者:
Christiansen, Elisabeth;Due-Hansen, Maria E.;Ulven, Trond
通讯作者: Ulven, Trond
DOI: 10.1021/jm8010178
发表时间: 2008-11-27
影响因子: 7.3
作者:
Christiansen, Elisabeth;Urban, Christian;Ulven, Trond
通讯作者: Ulven, Trond